34 related articles for article (PubMed ID: 7530217)
1. Rapamycin but not FK506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factors.
Cooper MH; Gregory SH; Starzl TE; Wing EJ
Transplantation; 1994 Feb; 57(3):433-9. PubMed ID: 7509089
[TBL] [Abstract][Full Text] [Related]
2. Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action.
Cardenas ME; Cruz MC; Del Poeta M; Chung N; Perfect JR; Heitman J
Clin Microbiol Rev; 1999 Oct; 12(4):583-611. PubMed ID: 10515904
[TBL] [Abstract][Full Text] [Related]
3. Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats.
Lesovaya EA; Kirsanov KI; Antoshina EE; Trukhanova LS; Gorkova TG; Shipaeva EV; Salimov RM; Belitsky GA; Blagosklonny MV; Yakubovskaya MG; Chernova OB
Oncotarget; 2015; 6(12):9718-27. PubMed ID: 25991667
[TBL] [Abstract][Full Text] [Related]
4. On the action of cyclosporine A, rapamycin and tacrolimus on M. avium including subspecies paratuberculosis.
Greenstein RJ; Su L; Juste RA; Brown ST
PLoS One; 2008 Jun; 3(6):e2496. PubMed ID: 18575598
[TBL] [Abstract][Full Text] [Related]
5. Male hypogonadism in cirrhosis and after liver transplantation.
Foresta C; Schipilliti M; Ciarleglio FA; Lenzi A; D'Amico D
J Endocrinol Invest; 2008 May; 31(5):470-8. PubMed ID: 18560267
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin.
Bierer BE
Proc Assoc Am Physicians; 1995 Apr; 107(1):28-40. PubMed ID: 8630742
[No Abstract] [Full Text] [Related]
7. Cyclosporin A, rapamycin and FK506 decrease prolactin release from rat pituitary cells in primary culture.
Wera S; Zheng L; Hooghe-Peters EL; Belayew A; Martial JA; Velkeniers B
Endocr Res; 1995 Aug; 21(3):623-33. PubMed ID: 7588431
[TBL] [Abstract][Full Text] [Related]
8. The immunosuppressive drugs cyclosporin A and FK506 inhibit calcineurin phosphatase activity and gene transcription mediated through the cAMP-responsive element in a nonimmune cell line.
Schwaninger M; Blume R; Oetjen E; Knepel W
Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):541-5. PubMed ID: 7509460
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporin A and FK506 depends on the promoter context.
Siemann G; Blume R; Grapentin D; Oetjen E; Schwaninger M; Knepel W
Mol Pharmacol; 1999 Jun; 55(6):1094-100. PubMed ID: 10347253
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cAMP-responsive element-mediated gene transcription by cyclosporin A and FK506 after membrane depolarization.
Schwaninger M; Blume R; Oetjen E; Lux G; Knepel W
J Biol Chem; 1993 Nov; 268(31):23111-5. PubMed ID: 7693684
[TBL] [Abstract][Full Text] [Related]
11. Osteoblastic differentiation is enhanced by rapamycin in rat osteoblast-like osteosarcoma (ROS 17/2.8) cells.
Ogawa T; Tokuda M; Tomizawa K; Matsui H; Itano T; Konishi R; Nagahata S; Hatase O
Biochem Biophys Res Commun; 1998 Aug; 249(1):226-30. PubMed ID: 9705862
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin, FK506 and cyclosporin A inhibit human prolactin gene expression.
Wera S; Belayew A; Martial JA
FEBS Lett; 1995 Jan; 358(2):158-60. PubMed ID: 7530217
[TBL] [Abstract][Full Text] [Related]
13. [Mechanism of action of the new immunosuppressants: cyclosporin A, FK 506 and rapamycin].
Rondeau E
Nephrologie; 1992; 13(3):137. PubMed ID: 1379348
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
